Inactive Instrument

Highlights Parnell Pharmaceuticals Holdings Ltd Nasdaq

Equities

AU0000XINEU9

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	20/06/22	CI
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million	27/01/21	CI
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners made an offer to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $7.2 million.	20/12/20	CI
Parnell Pharmaceuticals Announces Nomovid Antiviral Nasal Spray	23/09/20	CI
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	13/10/19	CI
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Full Year Ended 31 December 2018; Provides Earnings Guidance for the Year 2019	04/04/19	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2018; Revises Revenue Guidance for the Year 2018	02/11/18	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018; Revised Earnings Guidance for the Full Year 2018	03/08/18	CI
Parnell Pharmaceuticals Holdings Ltd Reports Audited Earnings Results for the First Quarter Ended March 31, 2018; Revises Earnings Guidance for the Year 2018	28/04/18	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Earnings Guidance for the Year 2017	17/08/17	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2016; Provides Earnings Guidance for the Year 2017	21/03/17	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2016; Provides Revenue Guidance for the Full Year 2016 and 2017	02/11/16	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016; Provides Revenue Guidance for the Year 2016	04/08/16	CI
Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial	31/05/16	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2015; Provides Revenue Guidance for the Year 2016	23/02/16	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	21/10/15	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Un-Audited Earnings Results for the Six Months Ended June 30, 2015; Re-Affirm Earnings Guidance for the Fiscal Year 2015	11/08/15	CI
Parnell Pharmaceuticals Holdings Ltd Announces Positive Top-Line Pivotal Trial Results for Zydax	18/06/15	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2015	22/04/15	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2014; Provides Revenue Guidance for Second Half of 2014 and Full Year of 2015	25/02/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Parnell Pharmaceuticals Holdings Ltd Nasdaq

Equities

AU0000XINEU9

Highlights

Filters